0001209191-17-046029.txt : 20170721
0001209191-17-046029.hdr.sgml : 20170721
20170721200721
ACCESSION NUMBER: 0001209191-17-046029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17977416
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-19
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2017-07-19
4
M
0
20000
77.31
A
119335
D
Common Stock
2017-07-19
4
S
0
20000
161.00
D
99335
D
Common Stock
2017-07-21
4
S
0
800
158.05
D
98535
D
Common Stock
2017-07-21
4
S
0
1300
158.90
D
97235
D
Common Stock
2017-07-21
4
S
0
500
160.04
D
96735
D
Common Stock
2017-07-21
4
S
0
4461
161.44
D
92274
D
Common Stock
2017-07-21
4
S
0
1564
162.07
D
90710
D
Common Stock
882
I
401(k)
Stock Option
77.31
2017-07-19
4
M
0
20000
0.00
A
2024-02-04
Common Stock
20000
21250
D
Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $158.05 (range $157.48 to $158.37).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $158.90 (range $158.61 to $159.53).
Open market sales reported on this line occurred at a weighted average price of $160.04 (range $159.64 to $160.25).
Open market sales reported on this line occurred at a weighted average price of $161.44 (range $160.90 to $161.89)
Open market sales reported on this line occurred at a weighted average price of $162.07 (range $161.90 to $162.43).
The option vests in 16 quarterly installments from 02/05/2014.
Omar White, Attorney-In-Fact
2017-07-21